57894-0522 Rybrevant Faspro

Product NDC:

57894-0522

Brand Name:

Rybrevant Faspro

Generic Name:

AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)

Dosage Form Name:

INJECTION

Administration Route:

Subcutaneous

Substances:

Name: AMIVANTAMAB

Strength: 3520.0

Unit: mg/22mL

Name: HYALURONIDASE (HUMAN RECOMBINANT)

Strength: 44000.0

Unit: mg/22mL

Packages:

Code: 57894-0522-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-522-01) / 22 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Feb. 13, 2026

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Bispecific Antibody

Minor Class:

EGFR, MET

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox